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Some Notes on 
Abdominal Surgery • 
Frank Riggall, M.A., MD., 
F.R.C.P. & F.R.C.S. (Edin.), F.R.F.P.S. (Glas.) 
In this interesting and informative paper, Dr. F. Riggall 
takes us on an informal and an informative tour through the 
common paths of the acute abdomen. He directs us, in his 
characteristically lucid manner, into the light of some understand-
ing of the maze of difficulty in diagnosis of the acute abdomen. 
M y SUBJECT is such a common one that I would apologize for presenting it to a group of doctors except for the fact that as we 
grow older in the practice of surgery we realize we are aided in crises 
by being able to recall necessary information. A Latin motto says 
"repetitio magister studorium." By constant repetition we master the art 
of recalling pertinent information when most vitally needed. 
As students we were taught that the history of any illness was of 
paramount importance. Years of practic~ tell us that histories are im-
portant when they are given by people who can think, who have words 
with which to clothe their thoughts, and who have some intention of 
telling the truth. In taking histories it is important to keep the questions 
simple and a doctor should remember that a man may be known as much 
by his questions as by his answers. Diagnosis is made easier in cases of 
acute abdomen by obtaining clear, definite answers to the questions: 
{1) When did it begin? 
{2) Where did it begin? 
{3) Where is it now? 
( 1) When did it be gin? The answer to this question should tell us of a 
sudden or gradual onset. If sudden, one thinks of a perforation or an 
acute obstruction; if gradual, one thinks of inflammatory processes, 
acute or chronic obstructions. A definite answer is important from 
another aspect because it should be a surgical t:ule that abdominal pain 
of more than six hours duration demands surgery until proved other-
wise. 
• Paper presented before the Pan American Medical Conference, Miami Beach, Florida, 
October 2~, 19:52. 
MAY, 1953 
---Abdominal Surgery--------------
(2) Where did it begin? Professor F. R. Miller of St. Andrews University 
has shown how helpful the answers to this question can be. He reminds 
us that the paired structures of the abdomen have paired nerve supplies 
which produce pain on the side of the organ affected. The single struc-
tures of the abdomen develop in the midline and have a single nerve 
supply which the organs take with them to their adult locations. From 
this we see why the pain of gall bladder or appendicular inflammation 
should begin in the midline and later pass laterally. This knowledge 
tells us why tubo-ovarian or renal pain begins on the affected side and 
stays there. This is important in the surgery of approach. It is some-
times difficult, for example, to differentiate between surgical conditions 
of the right kidney and the gall bladder. The surgeon may wonder 
whether his incision should be made anteriorly or posteriorly. By 
eliciting information that the pain began in the midline one can approach 
the gall bladder with confidence. 
(3) Where is it now? From this query we ascertain if the pain has re-
mained localized as in digestive ulcer penetrating the pancreas; referred as 
occurs from loin to groin with ureteral stone; or transferred as happens in 
cases of appendicitis where the pain shifts from midline to right lower 
quadrant. 
Inflammations are the most common causes of acute abdomen 
though perforations and obstructions are the most spectacular. The 
most common inflammation in the abdomen is acute appendicitis, and 
this makes the right lower quadrant a convenient place to begin an 
anatomical and pathological tour of the abdom'en. 
The pain of appendicitis, for all practical purposes, begins in the 
midline around the navel and passes, after a variable time, to the right 
lower quadrant. It begins gradually. It increases in severity. The pain 
comes before vomiting. When fully developed pain and discomfort 
are on the right side. Diagnosis is simple in the male but occasionally 
complex in the female. When difficulty of diagnosis arises in the fe-
male, it is helpful to recall that right tubo-ovarian inflammation begins 
on the right side. Tubo-ovarian inflammation is not usually confined 
to one side. There is discomfort or pain on moving the uterus from 
side to side or from front to back during bimanual examination. With 
right tubo-ovarian inflammation the pain is often worse when the tissues 
are stretched by moving the uterus to the left. Right tubal pregnancy 
may cause confusion, but the menstrual history should aid greatly in 
differentiation. I do not believe it is possible to differentiate between 
appendicitis and inflammation caused by the spilling of blood onto the 
peritoneum by a ripened, ruptured Graafian follicle of the right ovary. 
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In both sexes a stone in the lower right ureter can create difficulty 
in diagnosis. Twenty-five years ago studies of the surgical material in 
one large clinic in Vienna showed that 10ro of the patients operated 
upon for a right ureteral stone had previously undergone an appendec-
tomy without relief. This should not have happened. The stated 
questions will produce answers showing that the pain began on the right 
side and was referred to either the testicle or the labium majus. 
Years ago, Moynihan said that there were two kinds of appendicitis: 
the acute and that for revenue only. He was not familiar with a patho-
logical condition which is being recognized with increasing frequency. 
The symptoms and signs suggest appendicitis, but they are not quite 
dear cut and definite. In self-defense the surgeon opens the abdomen 
and finds the appendix normal. He next examines the lower ileum 
without finding a Meckel's diverticulitis. Continued search shows the 
mesentery studded with inflammed glands which range from pinhead 
size to strawberry size. The condition is acute non-specific mesenteric 
lymphadenitis whose cause is unknown. Routine appendectomy should 
be done and a gland removed for biopsy so that the nature and fre-
quency of the disease may be studied and recorded. 
In the right flank acute conditions are almost always muscular in 
origin. Rarely, a ureteral stone arrested at the pelvic brim will cause 
pain in the flank. Still more rarely, before the characteristic rash ap-
pears, the pain of herpes zoster may be felt in the flank . 
The biliary tract is the most frequent cause of acute abdominal 
symptoms in the right upper quadrant and a stone in the tract is more 
coronion than inflammation without a stone. Because the biliary tract 
develops embryologically as a budding off from the primitive digestive 
tube, the pain of a stone or an inflammation begins in the midline. It 
quickly moves to the right hypochondrium - so quickly that accu.rate 
answers a-re needed to the question: "Where did it begin?". Acute right 
hydronephrosis is a less frequent offender than the biliary tract, and acute 
obstruction of the hepatic flexure of the colon comes third in frequency. 
In neither of these does the pain begin in the upper midline and pass 
laterally. 
Acute pain in the epigastrium may be due to affections of the duo-
denum, stomach, pancreas, spasm of the lower end of the esophagus, 
diaphragmatic hernia of the paraesophageal type, and rarely, to coronary 
thrombosis. Coronary thrombosis is usually seen by the physician, but 
occasionally imitates an upper abdominal catastrophe and it may be very 
difficult to differentiate these two conditions. If there is any pain at 
all behind the sternum, coronary thrombosis should be remembered, but 
in the absence of such pain I have mistaken coronary thrombosis. My 
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only comfort is derived from other surgeons telling me that they have 
done likewise. A great surgeon told me that sometimes he was only 
able to differentiate the two with certainty when early in the course of 
an operation for a supposed upper abdominal catastrophe, the patient's 
condition under anesthesia rapidly aroused grave concern ! 
A perforated digestive ulcer of the stomach or the duodenum has 
a preceding history of dyspepsia, though the history may be short. Pan-
creatic pain is rarely confined to the upper midline, usually passes into 
the left hyponchondrium and may be severe in the midline of the back 
in the lower dorsal region. Spasm of the lower end of the esophagus 
gives pain, often severe, behind the xiphoid process. The intensity of 
the pain varies from half hour to half hour, is somewhat relieved by hot 
drinks and alkalies, is not referred, and is preceded by nervous stress and 
strain. Often a history of previous milder attacks can be obtained. 
Diaphragmatic hernia is usually easy to diagnose, if one thinks of it, and 
may be suspected when relief is obtained by inclining the trunk and 
head upwards. 
The left upper quadrant of the abdomen is not a frequent site of 
acute pain. One should always remember that pancreatic pain is quite 
commonly felt in the left upper quadrant, and of course, the characteris-
tic feature of pancreatic pain due to acute inflammation is its severity. 
Quite often one-third to one-half a grain of morphine is required to 
produce relief. Occasionally, the pain of coronary thrombosis may be 
referred to the left upper quadrant, but the diagnostic difficulties of this 
imitator have been pointed out. Trauma to the spleen may produce pain 
in this area, but the history of trauma alone is enough to alert the sur-
geon to the possibility of splenic damage. Obstruction of the splenic 
flexure causes more difficulty in diagnosis of colonic obstruction than 
any other portion of the colon, but when the obstruction has progressed 
to the point of producing; acute pain, there is a preceding history of 
colonic dysfunction. Renal conditions have been discussed in connec-
tion with the right upper quadrant. 
In connection with the left flank there is nothing further to add, 
but in the left lower quadrant a ureteral stone may be difficult to dis-
tinguish from diverticulitis. Indeed it is very important to remember the 
possibility of diverticulitis as a source of acute trouble in the left lower 
quadrant. Ureteral stone pain will be referred to the bladder, testicle, 
or labium majus and will often cause tenderness in the costorenal angle. 
The pain of diverticulitis in the early stages is present in the left lower 
quadrant with ocassionally reference to the suprapubic area. In the 
late stages of diverticulitis perforation may occur through the skin, the 
bladder, rectum or vagina, and burrowings of the pus in these directions 
will produce some alteration in the picture. 
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In the hypogastrium a distended bladder or a degenerating uterine 
fibroid may produce pain. A catheter solves the first problem and a 
bimanual examination the second. 
In all cases of .acute abdomen the ordinary and extraordinary sites 
of hernia must be examined. The ordinary sites are inguinal, femoral, 
and umbilical. The extraordinary sites are incisional, obturator-high 
up on the medial surfac~ of the thigh, gluteal-in the buttock, lumbar 
-over the iliac crest, and perineal. 
It will be seen that the problem of the acute abdomen is U$ually 
solved by weighing and judging the evidence. In cases where doubt 
remains we should remember the ancient myth of Pandora and the box. 
From it we learn that after Pandora opened the box and loosed upon 
the world Furies, Sorrows and Pestilences, she hurriedly shut the lid. 
One condition was left inside. That condition was Hope, and where 
doubt remains the surgeon should open the abdomen and look in. 
It is safer to operate and see than to wait and see. 
8~ iMIU ••• 
Diagnosis : a physician's forecast of disease by the patient's pulse and purse. 
Erudition : dust shaken out of a book into an empty skull. 
Homeopathist: the humorist of the medical profession. 
Belladonna: in Italian a beautiful lady; in English a deadly poison. A striking 
example of the essential identity of the two tongues. 
Cynic: a blackguard whose faulty vision sees things as they are, not as they 
ought to be. 
Idiot: a member of a large and powerful tribe whose influence in human affairs 
bas always been dominant and controlling. 
Prescription: a physician's guess at what will best prolong the situation with 
least harm to the patient. 
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Functional Uterine Bleeding: 
W. J. Hannah, '53 
Functional uterine bleeding is not uncommonly found in 
practice and it confronts the practitioner with a challenge in diag-
nosis and management. W. J. Hannah, in this excellent review 
of the subject, discusses the various forms of therapy and their 
advantages and disadvantages. 
T HE TERM functional uterine bleeding, in general, refers to that type of abnormal uterine bleeding which has no organic basis. 
It is estimated that this type of bleeding comprises from 15 to 201o 
of all bleeding seen in gynecologic practice, so that the diagnosis and 
proper management of this condition constitutes a major challenge to 
the practising physician. 
Oinical Olaracteristics 
The bleeding may be one of three types: 
1. Menorrhagia-this may be a moderate excess of menstruation, or 
may be severe enough to produce profound circulatory changes and 
gross anemia; the duration of the period is usually prolonged as 
well as the per minute flow. 
2. Metrorrhagia-irregular bleeding is quite characteristic of this con-
dition. 
3. Meno-metrorrhagia-most cases display some degree of both pro, 
fuse bleeding and irregularity. 
Functional uterine bleeding may occur at any age during the child-
bearing years and occasionally occurs outside the reproductive period. 
Generally speaking 55 to 60% of all cases take place between the ages 
of 35 to 50; wro of cases are seen about the age of puberty; the re-
mainder are distributed uniformly throughout the intervening period of 
menstrual life. 
Pain may or may not be associated with the bleeding, but it is not 
a characteristic feature. 
Physiologic Processes 
Normal Physiology 
To properly appreciate the mechanisms underlying this morbid 
condition, a brief review of the factors controlling normal menstruation 
should be considered. 
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In this regard, the anterior pituitary and the ovary are the prime 
movers, and the endometrium merely a target organ; after each period 
is over and the endometrium has been shed, the follicle-stimulating hor-
mone from the pituitary stimulates the formation of Graafian follicles 
in the ovary; these in turn produce estrogen which, among other things, 
produces proliferative changes in the endometrium; when the blood 
estrogen has reached a critical level, the production of F.S.H. is inhibited 
and in its place, luteinizing hormone is liberated causing first, the rup-
ture of one Graafian Follicle (i.e. ovulation) and secondly, the formation 
of a corpus luteum in its place; the corpus luteum under continued 
stimulation of L.H. liberates progesterone, which among other things, 
creates secretory changes in the endometrium. Roughly fourteen days 
after ovulation, the blood levels of estrogen and progesterone drop to 
a low level and one or two days later the endometrium sheds. Accord-
ing to Markee, this shedding of the endometrium is due to a spasm of 
the spiral arterioles supplying the endometrium causing an ischemia 
followed by slough. This normally lasts from three to six days, at the 
end of which time the cycle begins again. 
Thus, it can readily be seen that the normal functioning of mens-
truation de.pends upon a delicate hormonal balance between the anterior 
pituitary and ovary, as well as the relative receptivity and refractivity 
of th uterine endometrium. This latter factor is difficult to assess and 
undoubtedly varies in different individuals. 
Abnormal Physiology 
In a vast majority of cases of functional uterine bleeding, the ob-
served phenomena are to be explained by a failure of ovulation with an 
abnormally persistent estrogen output. Since no corpus luteum is formed 
no progesterone is produced and thus not only is a secretory type of 
endom·etrium prevented from being formed, but also the excretion of 
estrogen is delayed by virtue of the fact that no progesterone is present 
to help bring about its breakdown by the liver into its excretion pro-
ducts, estrone and estriol; thus with a persistently high level of estrogen 
in the blood, a hyperestrin or hyperplastic "Swiss-cheese" type of en-
dometrium is formed and in most cases, this is the type of endometrium 
found on curettage. If we accept Markee's concept that endometrial 
bleeding occurs when the blood level of estrogen either falls below a 
critical upper level, or is raised above a critical lower level, that is, there 
is a rather limited intermediate range of blood estrogen level during 
which endometrial bleeding occurs and outside that range no bleeding 
occurs, and there is considerable evidence to support this concept, then 
the bleeding which occurs in the anovulatory type of functional bleeding 
is explained by the estrogen level undergoing temporary drops into the 
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bleeding range by means of an inhibition of the pituitary gonadotrophic 
function by a certain high level of estrogen, which varies in different 
women. 
Not all functional bleeding, however, can be explained by failure 
of ovulation; in a smaller percentage of cases, ovulation has occurred 
as proven by the demonstration of a secretory or progestational type of 
endometrium in the curettings of such patients. McKelvey suggests that 
the bleeding here may possibly be due to the production of an abnormal 
form of progesterone or a prolonged progesterone effect. 
In an even smaller percentage of cases, an atrophic endometrium 
may be the site of functional bleeding. The bleeding here could be 
explained on the basis of temporarily raising a low estrogen level up 
into the "bleeding range" or may be due to an endometrium which is 
refractory to the growth effects of estrogen, but nevertheless is sensitive 
to the fluctuations in estrogen brought about by the ovarian-pituitary 
interplay. 
Diagnosis 
Many gynecologists agree that one of the most difficult things 
about functional uterine bleeding is the establishment of an accurate 
diagnosis. 
The diagnosis is best made by exclusion only. All studies, both 
local and general should be exhausted so that organic disease of the 
body in general, or of the pelvic organs in particular, may be ruled out. 
General studies should include investigation for any endocrine dys-
function, especially thyroid disease; for any blood dyscrasias, such as 
leukemia, aplastic anemia, and thrombocytopenic purpura. 
Locally, apart from a thorough pelvic examination, the most im-
portant single diagnostic aid at our disposal is a diagnostic curettage. 
In any case of abnormal, persistent uterine bleeding, this should be 
done, and in many cases of organic uterine disease, this is the only means 
of making the diagnosis; if organic disease can be definitely excluded 
by gross and microscopic examination of the curettings then a diagnosis 
of functional bleeding may safely be made. In this case, the endometrium 
is usually of the proliferative or hyperplastic type, but as was said 
earlier, it may correspond to that found in any of the normal menstrual 
phases. 
Treatment 
Like any abnormal condition, the exact mechanism of which is im-
perfectly understood, the treatment has been unusually varied; therefore, 
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a review of the various methods used will be presented with emphasis 
placed on the more effective methods. 
First of all the treatment may be divided up into two broad groups: 
A. General Measures 
1. Sometimes these patients have lost a considerable amount of 
blood, so that a transfusion may be necessary. 
2. Secondary anemia is frequently seen therefore iron should be 
given. 
3. Any protein deficiency in the diet should be corrected. 
4. Vitamin B complex in large doses is recommended by some 
authorities. This aids liver function which appears to be impair-
ed in this condition. 
5. Thyroid therapy-Novak and others report that only in a very 
few cases does thyroid deficiency play any part in the patho-
genesis of this type of bleeding. In spite of this, thyroid extract 
is of great value not only in functional uterine bleeding, but also 
in most functional female disorders. It is placed under general 
measures because its use in most cases is empirical and it exerts 
no specific action unless there is actual hypothyroidism in which 
case its value is obvious. 
B. Specific Therapty 
Specific treatment may itself be divided into two important groups : 
(a) Treatment in the younger age group and during reproductive 
years. 
(b) Treatment at or near the menopause. 
(a) Treatment in the Younger Patients 
It must be borne in mind, first of all , that irregularity and excessive 
menstrual flow at the menarche is far from uncommon and that a large 
percentage of these cases will recover spontaneously; thus it becomes 
the responsibility of the physician to decide when the condition has 
ceased to be simply a slight aberration of a normal phenomenon and 
has become definitely pathological. This may sometimes be difficult 
to decide, but in any case of doubt, correct diagnosis and treatment 
should be started at once. 
1. Curettage--Apart from its diagnostic value, curettage has a very 
prominent therapeutic effect. Jones in a series of cases in 1949 re-
ported that curettage provided a complete cure in 42«7'0 of his cases. 
Even if a full cure is not obtained a large number of patients resume 
normal cycles for a period of months at the end of which time the 
curettage may be repeated. 
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It is of great value when the patient is bleeding profusely and 
should be done as soon as possible - it rarely fails to check what 
might otherwise prove to be a disastrous haemorrhage although such 
cases are rather uncommon. 
Taylor, of the University of Colorado, suggests that the rationale 
of curettage as a therapeutic measure is that the target-organ, the 
uterus, is not fitting into the pattern and by removing the endome-
trium we might then expect the regrowth of a more satisfactory 
participating end-organ. 
2. Hormonal Treatment-Even though the underlying cause of this con-
dition is in the pituitary, as yet attempts to correct it at this level 
have been. disappointing, so it must be attacked at the ovarian level. 
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(i) Estrogens 
The rationale for the use of estrogen therapy becomes obvious 
when we remember that if we raise the blood estrogens to a certain 
level the endometrial bleeding will cease; in addition, estrogens in-
hibit the production of the pituitary F.S.H. and so reduces ovarian 
stimulation, and thus . indirectly cause follicular atresia. This, in 
effect, produces a temporary castration which is the same effect 
created by irradiation with none of the obvious dangers of the latter. 
Estrogenic therapy is one of the most popular means of manag-
ing benign uterine bleeding, but in recent years E. C. Hamblen of 
Duke University has combined estrogens with progesterone to obtain 
a natural cyclic effect. This method of treatment will be discussed 
shortly. 
Estrogens are probably the best single hormonal treatment for 
that type of bleeding in which ovulation has occurred. 
(ii) Progesterone 
This hormone acts by reducing estrogenic activity, by stopping 
the proliferative changes in the endometrium, and inducing secretory 
changes, thus producing a more physiological endometrium. 
It is used either intramuscularly or sublingually and has pro-
duced good results in a large number of cases. Its chief disadvantage 
is its expense because it must be given in fairly large doses. 
(iii) . Cyclic Therapy 
This implies a regulated use of both estrogen and progesterone; 
the idea behind this form of treatment is to "chemically prime" the 
pituitary, ovary, and endometrium to resume a normal cyclic activity 
and its use in finding increasing favour throughout the North 
American continent. 
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The m.ethod of treatment as originally recommended by Ham-
blen is to begin with an estrogen, such as estrone sulphate, adminis-
tering 7.5 mgm. daily until the bleeding ceases. This dose is in-
creased by 50«J'o if the bleeding has not definitely decreased by the 
third day of treatment. The estrogen is maintained for 20 days; 
during th last 10 days, 60 mgm. of oral progesterone is given daily. 
Withdrawal bleeding then occurs and on the 4th or 5th day of bleed-
ing, the course is repeated again with half of the dosage used. He 
states that three or four such series usually restores normal function. 
Since this form of therapy was introduced several modifications have 
come into vogue which include the use of diethyl stilbestrol and 
sublingual or intramuscular progesterone, which provides cheaper 
and more effective treatment. Many gynecologists withhold the 
progesterone until the end of the estrogen course. However, the 
principle remains essentially the same. 
( iv) T esto·sterone 
This hormone inhibits the pituitary, inhibits follicular produc-
tion, and produces atrophy of the endometrium and its vascular bed. 
It has produced favourable results in many cases if the dosage is not 
too high-Novak gives from 30 to 50 mgm. a week. However, 
there is the ever-present danger of masculinizing changes which in 
some instances may be permanent. 
(v) Anterior Pituitary-like Hormones 
Theoretically,. the gonadotropins should be the most rational 
form of therapy since it is a disturbance in the hormonal output of 
the pituitary which is at the root of the trouble; however,. these hopes 
have not been sustained and these hormones are not commonly used. 
3. Protamine Sulphate and Toluidine Blue-Rumbolz of the University 
of Nebraska reports excellent results using these compounds; ac-
cording to him, an inhibitor to clotting is present in this condition 
and these substances neutralize this inhibitor. It is too early yet to 
assess the value of this treatment. 
4. Psychic Management-It is essential, especially at puberty, to reas-
sure these patients, to explain to them the nature of their condition, 
and that it may persist for some time, but that the prospect of complete 
cure in a relatively short time may reasonably be expected. 
5. Radical Methods-The use of radiation, or surgical correction of this 
condition in younger patients cannot be too strongly condemned, un-
less, despite all conservative methods of management the patient's 
condition continues to deteriorate. In such cases light radiotherapy 
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to the ovaries may be tried in the hope of checking the condition; 
even light dosage may produce irreversible changes in sensitive 
ovaries. 
Complete irradiation of the ovaries or hysterectomy should be 
reserved for those very few cases where all other methods including 
time fail. 
(b) Treatment At or Near the Menopause 
The management of the condition is much simpler in this age 
group, since it is not essential to preserve either ovarian function or the 
uterus; thus the treatment, after diagnosis is made resolves itself, in 
general, into one of the two methods: 
1. Radiation-Many workers feel this is the treatment of choice, since 
it obviates the inconvenience and discomfort of surgery and is, in 
most cases, simple to perform and is very effective. 
It may be used in one of two ways: 
(i) Irradiation of ovaries-some ovaries are unusually refractive to 
radiation and may cause further bleeding. 
(ii) Intra-uterine radium-Hundley and workers at the University of 
Maryland are very enthusiastic about this form of treatment, but 
most gynecologists feel that it has a very limited use and there is 
always the danger of the radiation producing malignant changes in 
the already hyperplastic endometrium. 
2. Surgery-Surgical removal of the uterus is favoured by a large num-
ber of gynecologists. Vaginal hysterectomy, in competent hands, is 
a relatively simple and safe op_eration and it has the special merit 
of not only completely curing the condition but at the same time 
removing a potential focus of carinoma. 
Opinion is divided on the question of radiation versus surgery. 
However, it is generally felt that hormonal treatment is not as good as 
either of these two in this group-it is expensive and many feel that it 
may definitely be carcinogenic, though opinion here is again divided . . 
Snonary 
A review of the physiological processes underlying functional 
uterine bleeding has been presented, emphasizing that most cases are of 
the anovulatory type, but a small percentage may show normal men-
strual, or even atrophic endometrial changes. 
The diagnosis is made by exclusion of any organic disease by means 
of history, physical examination, pelvic examination and D. & C. 
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The management is divided up into: 
(a) General Measures 
(b) Specific Measures 
The specific measures are further divided into: 
(a) Treatment of younger age group. 
This is broken down into: 
1. Therapeutic curettage. 
2. Hormones - those which appear to be most effective 
are estrogens and progesterone, either singly, or com-
bined as cyclic therapy. 
(b) Treatment at or near the Menopause-the methods here 
are: 
1. Radiation. 
2. Surgery. 
The advantages and disadvantages of each form of therapy has been 
considered. 
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Autonomic Drugs: 
with Special Reference to Adrenergic Blockade* 
C. W. Gowdey, B.A., M.Sc., D.Phil. (Oxon.). 
This clinical evaluation of the numerous adrenergic blocking 
agents wiii be of considerable interest to ali. Dr. Gowdey, in 
reviewing the recent literature, has presented a concise, critical 
review of the value of chemical sympathectomy in the treatment of 
peripheral vascular disease. 
T HE CLINICAL application of drugs affecting the autonomic nervous system is increasing rapidly as newer, more potent, more specific 
synthetic drugs are introduced. The number and complexity of these 
compounds, and the confusion caused by the numerous trade names, 
and by premature enthusiastic claims, make one wonder whether the 
pendulum has swung too far away from Osler's tenet that the practi-
tioner needs only ten drugs. 
Certain physiological and anatomical aspects of the autonomic 
nervous system are important for an understanding of the action of 
autonomic drugs. One of the chief differences between the sympathetic 
and parasympathetic divisions is in the extent to which their fibres 
ramify. A preganglionic sympathetic fibre may traverse a considerable 
distance of the sympathetic chain and pass through several ganglia before 
it finally synapses with a postganglionic neurone; it also synapses with 
a large number of postganglionic fibres. In this .way the sympathetic can 
discharge as a unit, and does so in circum~tances of r~ge and fright. The 
parasympathetic system, on the other hand, has its · terminal ganglia very 
near or in the organs innervated, and therefore is· more limited and dis-
crete in its discharge of impulses. Cannon<1> summarized the distinctions 
between the two parts of the autonomic nervous system in this way, "The 
sympathetics are like the loud and soft pedals, modulating all the notes 
together; the cranial and sacral innervations are like the separate keys." 
A clear understanding of the response of various organs to autonomic 
nerve impulses makes it possible to anticipate the actions of many drugs. 
Generally speaking, the sympathetic and parasympathetic are physio-
logical antagonists; if one system inhibits a certain function, the other 
augments it. Many organs are innervated by both divisions of the 
autonomic, and the level of activity at any instant is the balance of the 
*Article received for publication, January, 1953. 
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results of the two influences. The activity of one system is usually in-
tensified by removal or paralysis of the other. Acetylcholine will faith-
fully imitate the effects of parasympathetic nerve stimulation, whereas 
belladonna alkaloids will prevent these effects. In the same way, 
Adrenaline and Noradrenaline imitate most, if not all, of the effects of 
sympathetic nerve stimulation. 
Clinicians have long made use of drugs such as Physostigmine and 
Pilocarpine, which imitate parasympathetic effects. Newer synthetic para-
sympathomirnetics include Methacholine (Mecholyl), Carbachol (Doryl), 
Neostigmine (Prostigmin), D.F.P. ( di-isopropyl fluorophosphate) and 
T.E.P.P. (tetrarethylpyrophosphate) . Many of the sympathomimeticshave 
also found their way into clinical medicine since the systematic investi-
gation by Barger and Dale <2 > in 1910 of sympathomimetic amines. 
A great deal of research has been done to develop more powerful com-
pounds with longer-lasting and less toxic effects. As a result, dozens of 
drugs with more or less sympathetic-like activity have appeared on the 
market. The differences among them are often more apparent from 
advertisements than from pharmacological investigation. A few of the 
newer, more popular synthetic sympathornimetics are: Phenylephrine 
(Neosynephrine) , Hydroxyamphetamine (Paredine), Naphazoline (Pri-
vine), Phenylpropanolamine (Propadrine) , and Methoxamine (Vasoxyl). 
Certain members of the sympathomimetic amine series have properties 
other than vasoconstriction which have been utilized clinically. An 
example of this is found in Amphetamine (Benzedrine) and Methamphe-
tamine (Desoxyephedrine, Desoxyn) , which are used a great deal as 
central nervous system stimulants. Another example is Isopropylarterenol 
(Isuprel, Aludrine) which actually causes vasodilatation; it is a powerful 
bronchodilator, however, and is used in the treatment of asthma. 
The parasympathetic blocking agents such as Atropine and Hyoscine 
have been used clinically for many years. Certain synthetic drugs such 
as Homatropine, Trasentine, Syntropan, and Methanthaline (Banthine) 
are also used now in the treatment of parasympathetic hyperactivity. 
Evelyn states in his review on autonomic drugs(3l that the short-term 
effects of Banthine have been fairly well established in the treatment of 
duodenal ulcer. Relief of pain occurs in about 90% of cases, usually 
within the first two days of treatment. He feels that careful, controlled 
studies over long periods will be required, however, to decide whether 
the percentages of unsuccessful results will be significantly smaller on 
Banthine than on conventional therapy. 
Until recently the effects of the sympathetic nervous system could 
be annulled by various means, but not by specific blockade, as the para-
sympathetic could be by the belladonna drugs. It is true that Dale demon-
strated adrenergic blockade experimentally by an ergot preparation in 
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1906, <4> but although ergot found clinical use as an oxytocic, inhibition 
of the sympathetic nervous system required concentrations toxic to the 
human. Thus Dale's blockade with ergot remained a laboratory cur-
iosity - a useful tool for pharmacologists, but of no clinical value. 
Sympathetic activity could be abolished, temporarily, by surgical pro-
cedure, and was antagonized by such central nervous system depressants 
as barbiturates and also by local anesthesia of the nerve trunks. 
"Chemical sympathectomy" (or "medical sympathectomy") is now 
possible, and it is proposed to review this part of autonomic drug action 
in somewhat more detail. Chemical sympathectomy can be produced in 
two ways: first, by blocking the sympathetic ganglia, and second, by 
blocking the sympathetic effector cells in the end-organ. Sympathetic 
ganglia are effectively blocked by Tetraethylammonium ion (Etamon), 
and by Penta- or Hexamethonium ion (Cs, Vegolysen). These compounds 
are being investigated clinically in hypertension and peripheral vascular 
disease. Although Tetraethylammonium does cause autonomic block-
ade, <5> this effect seems to be too transient to be valuable in the diagnosis 
or treatment of vascular spasm, and TEAC can only be given parenterally. 
Paton and Zaimis<6> investigated the methonium salts pharmacologically, 
and their results led directly to clinical trials of these agents. Arnold 
and Rosenheim(7> showed that an intravenous injection of 25 to 100 mg. 
of Hexamethonium Bromide produced a rapid and sometimes excessive 
fall of blood pressure in hypertensives in the horizontal position. This 
hypotensive effect lasted at least an hour, but postural hypotension still 
occurred after several hours. Many reports have come out in the past 
two years on the use of methonium compounds in hypertension. Some 
investigators, such as Locket, Swann, and Grieve,<&> were not enthusiastic. 
They tried both Pentamethonium and Hexamethonium Bromide in 34 
cases of persistent hypertension. Before starting the drugs, each patient 
was given two weeks' initial observation, routine treatment, and rest in 
bed. In every case the methonium compounds (given I.M. and orally) 
were hardly any more effective in lowering blood pressure than the bed 
rest period. When the drugs were given orally to these cases as out-
patients, they failed to lower or maintain a low blood pressure. One 
death and three probable cases of bromide intoxication, probably attribut-
able to the drug, were reported . They believe that the sedative effect 
of the bromide part of the compound, aided by ancillary factors, was one 
of the important factors in the subjective improvement of the patients. 
Hexamethonium is now available as the bitartrate salt to overcome the 
objection to the bromide ion. Others such as Smirk and Alstad <9>; 
Frankel<10>; Freis<11 >; and Turner<12> reported that the methonium com-
pounds are valuable in the reduction of hypertension. Smirk and Alstad 
conducted 150 tests on hypertensives of varied etiology and on 53 patients 
treated for 2 to 14 months, and concluded<9> that these drugs are the most 
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effective and generally applicable hypotensive agents. Blood-pressure 
reduction was associated with relief of dyspnea, pulmonary congestion, 
headache, papilledema, and retinal exudates (11 patients had malignant 
hypertension). Treatment must be individualized and the patients 
selected carefully; great blood-pressure reductions may be inadvisable in 
patients with much cerebral or coronary sclerosis because of the danger 
of thrombosis, etc. They state that, "attempts at treatment which do not 
take account of individual responsiveness to the drugs, postural hypo-
tension, the effect of salt intake, the acquisition of tolerance, and numer-
ous other factors will flounder between the dangerous and the ineffec-
tual." Freis' experience<11 > confirmed that of Smirk; if properly admin-
istered Hexamethonium is an effective agent for reducing blood pressure 
in the majority of cases, including those with malignant hypertension; 
oral administration is not so reliable as parenteral; and the patient or a 
member of the family can be taught to administer the injections and 
record the blood pressure in the home, thus making long-term therapy 
feasible. Many clinicians might argue the advisability of having hyper-
. tensives take their own blood pressures. Frankel (Io) was quite enthus-
iastic, and also considered that oral administration was much l'ess effec-
tive than intramuscular. Turner<12l felt that no patient should be sub-
mitted to surgical sympathectomy for hypertension until a thorough trial 
with methonium had been made; likewise every patient with malignant 
hypertension should be similarly treated. 
Besides the relatively rapid development of tolerance, all of the 
reports stress the potential dangers, warn against indiscriminate treat-
ment, and recommend that the initial assessment be made in hospital. 
The dangers of postural hypotension, of coronary or cerebral throm-
bosis in patients with advanced arteriosclerosis, and of impaired renal 
function from lowering the blood pressure are very important considera-
tions. Neither the methonium compounds nor other ganglionic blocking 
agents will block the sympathetic ganglia, without also blocking the 
parasympathetic. Thus, besides the undesirable postural hypotension, 
etc., mentioned above, other side effects, e.g., dry mouth, constipation, 
blurring of vision and photophobia referable to parasympathetic blockade 
are often observed. In fact, Hexamethonium has been used in this regard 
to treat the pain of gastric ulcer. Although the final answer is not known 
regarding the use of methonium compounds in hypertension the litera-
ture suggests that most clinicians will limit their application to severe 
cases (e.g. , malignant hypertension) , to short-term disorders (toxemia 
of pregnancy); to dangerous episodes {hypertensive encephalopathy), 
and to relief of symptoms such as headache due to hypertension. Only 
a long and carefully controlled trial can tell whether methonium may 
reasonably be given to young patients with benign hypertension, with a 
view to postponing cardiovascular or renal lesions<13l. 
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On theoretical grounds, chemical sympathectomy by blockade of the 
sympathetic effector cells would appear to be preferable, but the problem 
is not yet resolved. Various terms such as "adrenergic blocking agent," 
"adrenolytic" and "sympatholytic" have been used to describe this peri-
pheral action. Nickerson <14> prefers the expression ·:adrenergic blocking 
agent," because he points out that neither nerve ending nor chemical 
mediator nor effector cell is "lysed" by these compounds. The other 
words are, however, still widely used. True adrenolytic action, ·i.e., 
chemical destruction of adrenaline, is shown by such oxidizing agents 
as potassium permanganate. All adrenergic blocking agents appear to be 
more effective in blocking the action of circulating sympathomimetics 
than they do against sympathetic nerve stimulation, but the difference is 
probably a question of dosage and permeability, not of fundamental 
mechanism of action. Jang<u> found that a whole host of compounds 
could be either synergistic or antagonistic to adrenaline, depending on 
their concentrations. 
Other naturally-occurring adrenergic blocking agents besides ergot 
are the alkaloids Yohimbine, Corynanthine, and Apocodeine, but these 
are not used today in therapeutics. The first synthetic blocking agents 
of any importance were the benzodioxane derivatives prepared by 
Fourneau. The best known and most active of this series are 883F and 
933F (the "F" for Fourneau; the latter is called Piperoxan (Benodaine) .) 
In 1939 Hartmann and Isler06l described a series of imidazoline com-
pounds, some of which were sympathomimetic and others were blocking 
agents. Further laboratory work<17• 18• 19l showed that Benzazoline 
(Prisco line) was a powerful adrenergic blocking agent. Swiss phar-
macologists continued to work with the imidazoline nucleus, and finally 
synthesized Regitine, which was introduced into Canada only this year. 
Other Swiss workers hydrogenated the ergot alkaloids ergocornine, ergo-
cristine, and ergokryptine in 1943<20>; these three are marketed as Hyder-
gine, which contains dihydroergocornine, dihydroergocristine, and 
dihydroergokryptine in equal proportions, and also separately. Dibena-
mine is an American preparation, a synthetic nitrogen mustard derivative, 
first described by Nickerson and Goodman in 1945<21 >. A new potent 
derivative of this series, Dibenzyline, is at present being tested clinically. 
Benzodioxane derivatives show a wide range of activity; some (883F) 
block primarily the responses to circulating sympathomimetics <22> <23l , 
while others {933F) can also block sympathetic nerve activity. The block-
ade by this series is rather weak, and they have other pharmacological 
properties: cardiovascular excitation of central origin, coronary constric-
tion, cardiac depression, analgesia, ganglionic excitation and adrenaline 
secretion<HJ . Currently, of this group, only 933F is receiving extensive 
clinical trials, mostly as an aid in diagnosing tumors of the adrenal 
medulla. Goldenberg, Snyder and Aranow<24l have worked out a dosage 
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range in which the drug produces an insignificant or moderate elevation 
in blood pressure in normal subjects. A similar amount produces a 
blood-pressure reduction if patients ~ave hypertension associated with a 
pheochromocytoma. 
·Priscoline and the chemicaJly-related Regitine are adrenergic block-
ing agents which both act peripherally. Besides inhibiting the effects 
of circulating sympathomimetics, they will in sufficient dosage also block 
sympathetic vasoconstriction. The pharmacological properties of Frisco-
line have been described by Meier and Mueller<17>, Ahlquist, Huggins 
and Woodbury<18>, and by Gowdey<19>. Grimson, Reardon, Marzoni and 
Hendrix<m described its clinical use in peripheral vascular diseases and 
in hypertension. Priscoline caused slight and inconsistent increases in 
pulse rate, cardiac output, and arterial blood pressure. Both normal 
patients and those with ischemic extremities showed increased cutaneous 
blood flow; Priscoline has vasodilating activity beyond its adrenergic 
block action(l9l . Grimson et aJ reported that single doses, with few ex-
ceptions, produced changes in the circulation of limbs equivalent to those 
produced by sympathetic block or sympathectomy. Results in treatment 
of Raynaud's disease were encouraging and unless evidence of toxicity 
or tolerance developed, sympathectomy was no longer recommended by 
Grimson et al. They also reported encouraging results in treating vaso-
spastic ischemia extremity problems and causalgia states. Priscoline has 
been tried in most peripheral vascular disorders, especially in Europe. 
Attempted treatment of hypertension by Priscoline yielded few encour-
aging results, and use of a Priscoline test did not aid in prediction of the 
results of sympathectomy. One of the advantages of Priscoline over some 
of the other blocking agents is that it may be given intravenously, intra-
muscularly, or orally. Occasional side effects of Priscoline are ortho-
static hypotension, tachycardia, nausea and goose flesh ; the insulin re-
quirement of diabetics may be reduced. Beckman<26> thinks Priscoline 
should be used very cautiously in peptic ulcer (because it increases acid 
gastric secretion) and in coronary disease. Small doses of Regitine given 
I.V. or orally will lower the blood pressure<21l, and may aid in the diag-
nosis of pheochromocytoma. 
Rothlin<28> has shown that Hydergine (the combination of three 
hydrogenated ergot alkaloids) instead of causing contraction of smooth 
musculature and vasoconstriction as do the parent compounds, actually 
dilates vessels and protects the effector organs from harmful adrenergic 
stimuli. The vasodilatation is thought due to both an action on the vaso-
motor centre and· to a direct action on vessels. Bradycardia, due to a 
central action, is partly inhibited by atropine. Hydergine also causes 
central sedation and potentiates barbiturates. Hydergine has been used 
to treat hypertension, particularly in Europe, and again the results 
vary<29>. Some are quite encouraging, but the necessity of frequent dosage 
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and the side-effects tend to Limit its usefulness. The European litera-
ture suggests that Hydergine will lower the blood pressure in about 50% 
of hypertensives, and will be ineffective in about 35%. Wilkins<3o> used 
dihydroergokryptine, given I.V., to lower the blood pressure following 
histamine injection in a case with pheochromocytoma. Animal experi-
ments suggest that Hydergine inhibits ectopic rhythms during cyclopro-
pane anesthesia, but Manning<31> found no significant protection in ex-
perimental coronary occlusion in dogs. Hydergine has been tried in a 
variety of peripheral vascular disorders, in toxemia of pregnancy, and 
angina pectoris. Final evaluation of its effectiveness is not yet possible. 
Side-effects include nasal congestion, nausea and vomiting, postural hypo-
tension, occipital headache, and gastric colic. Hydergine can be given 
orally, sublingually, intramuscularly and if necessary intra-arterially (in 
gangrene, etc.). Daily administration appears to yield the best results. 
Dibenamine has been thoroughly studied pharmacologically by 
Nickerson and Goodman <21 >. Two distinguishing features of the dibena-
mine-type blockade are its completeness and its duration. Extensive b~ock­
ade may persist for 3 to 4 days after a single injection <32l, and once an 
adequate block has been established, it cannot be overcome by massive 
adrenergic stimulation. Dibenamine has been tried in Buerger's and 
Raynaud's diseases, in acute arterial occlusion and in frostbite; it was 
generally found to produce good peripheral vasodilatation and often 
clinical improvement<14>. Dibenamine is too caustic to be given other 
than by dilute intravenous drip, and despite the utmost care thrombosis 
may occur at the site of injection. It may take several hours for the full 
blocking effect to be realized, even after IV injection. Side effects such 
as severe nausea and vomiting, visual impairment, loss of bladder control, 
central nervous system stimulation (restlessness, confusion, occasional 
convulsions) limit clinical use of the drug<26>. Postural hypotension and 
tachycardia are directly related to the adrenergic blockade. Dibenzyline is 
said to be more potent in its blocking action and is, therefore, expected 
to produce fewer undesirable reactions. 
The value of chemical sympathectomy compared to other methods 
of therapy is not possible to judge at the present time. Peripheral vas-
cular diseases, including Raynaud's and Buerger's disease, diabetic gan-
grene, acrocyanosis, frostbite, acute peripheral arterial occlusion, causal-
gic state, and chilblains have all been treated with one or more of these 
agents. All of them appeared to produce beneficial vasodilatation and 
may offer great promise, but adequate controls were often lacking and 
further investigation is indicated. Several of the adrenergic blocking 
agents have been used in the diagnosis of adrenal medullary tumors, but 
the reports usually deal with too few cases to allow objective evaluation. 
Some investigators believe that cardiac arrhythmias can be prevented in 
experimental animals by Dibenamine and Hydergine; others, however, 
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found no protective action. Recent animal studies also suggest that in 
certain kinds of experimental shock (hemorrhagic<n. Hl and traumatic<m) , 
adrenergic blockade may increase survival, but no clinical results are yet 
available. 
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l. 
2. 
3. 
Dr11g 
Nicotine 
Exogenous 
Acetylcholine 
Tetraethyl-
ammonium 
Hexamethonium 
Ephedrine 
Amphetamine 
etc. 
Exogenous 
Adrenaline 
Noradrenaline 
Effea 
Stimulation 
Inhibition 
Stimulation 
Stimulation 
Site of 
Action 
1. 
2. 
Dr11g 
Nicotine 
Exogenous 
Acetylcholine 
Tetraethyl-
ammonium 
Hexamethonium 
Physiostigmine 
Neostigmine 
DFP, etc. 
Mecholyl 
Exogenous 
Acetylcholine 
3. etc. 
Hydergine Atropine 
Dibenamine Inhibition Hyoscine 
Priscoline Banthine 
Effec-t 
Stimulation 
Inhibition 
Stimulation 
Stimulation 
Inhibition 
It is far too early to know how valuable chemical sympathectomy 
may be in the treatment of hypertension. All of the above-mentioned 
compounds have important disadvantages, such as too transient activity, 
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too many side effects, and the ever-present danger of postural hypo-
tension. If sympathetic blockade is complete, then postural hypotension 
is to be expected. This may be partly overcome by the use of abdominal 
and leg binders, and preliminary observations indicate that patients may 
in time compensate for postural changes in the presence of continued 
blockade<14>. This adjustment is probably similar to that occurring after 
extensive sympathectomy. Nor is it yet dear whether continuous therapy 
is feasible because of the development of tolerance. At the moment, 
studies are in progress in which Hexamethonium is being alternated with 
compounds such as Apresoline and Veratrum alkaloids in an effort to 
minimize both tolerance and toxicity. Undoubtedly short-term benefits 
are possible, but for long-term therapy with ambulant patients, it is prob-
able that none of the compounds presently under investiagtion offer the 
answer to hypertension. 
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D • Francis Staples Brien 
Recently, a group of undergraduate medical students were advised 
"when considering a hospital for internship, consider first the man 
will be your chief". The students, graduates, and staff at the 
.0. Medical School and Victoria Hospital are indeed fortunate to 
hav as Professor of Medicine an individual who exemplifies those 
qua ·ties that were in the mind of the speaker of those words. 
Professor Francis S. Brien was born in Windsor, Ontario and com-
pie d his elementary schooling there. He attended the University of 
To nto where he received his B.A. degree, and in 1933 was awarded 
his M.B. (medical) degree. After interning at the Toronto General 
Ho pital for three years, he took further post-graduate training in 
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London, England, where he received through examination his M.R.C.P. 
He returned to Canada and practiced internal medicine in Windsor un-
til 1942 when he joined the R.C.A.M.C. He served overseas in England 
and on the continent, finally attaining the rank of Lieutenant-Colonel. 
For his heroic and excellent work he was mentioned in dispatches on 
two occasions. Those who have heard Dr. Brien's lectures or have 
worked with him are familiar with the wealth of experience he gained 
during this period, and they associate many "gems" of medical know-
ledge with his anecdotes of army practice in Belgian hospitals. 
Towards the termination of hostilities in Europe, he did further 
work in the London (England) hospitals, and in 1945 was appointed 
Professor of Medicine at the University of Western Ontario Medical 
School. Soon after he was awarded a fellowship of the Royal College 
of Physicians of Canada and also became a Fellow of the American 
College of Physicians. Among his widespread medical interests, Prof. 
Brien has given much of his time working on the executive of the Royal 
College of Physicians and the Ontario Medical Association. 
Dr. "Frank" Brien is a keen enthusiast of hunting and fishing, and 
of late has become an even more ardent collector of stamps. He may 
be classed with the few medical men who possess the rare ability of not 
only being an outstanding medical teacher, but also a humanitarian. If 
one were to evaluate Professor Brien's contribution to medicine, the 
most outstanding dispensation would be the sound, common-sense type 
of thinking he has imparted to the many students and internes who have 
come under his tutelage. He possesses the ability and kindness that 
allows him to treat the great, the ordinary, and the dregs of our society 
with the same attitude of fairness and goodness; to him a patient is not 
a group of signs and symptoms but a whole person. 
Those of us who will soon leave the medical school and hospitals 
will readily recall his fine manner, his pleasant approach at the bedside 
or in the hallways, and his inimitable ability to wear those white, 
buttonless "clinic" coats! 
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Ventilation Studies: 
Their Value As Pulmonary Function Tests 
J. E. Merriman, M.D., C.M. 
The value of vmtilation studies as pulmotJa1'y function tests 
has not been app1'eciated by the majority of clinicians and it is 
only recently that an awakening interest in this subject has de-
veloped. In this article, D1'. f. E. Me1'1'iman discusses the value 
and limitations of these tests in clinical medicine. 
PROBABLY THE first reported use of a test for puimonary function was in 1846 when Jonathan Hutchinson 1 described the spirometer 
and the value of vital capacity measurements in the diagnosis of pul-
monary tuberculosis. During the last ten or fifteen years there has 
been an increasing interest in the use of pulmonary function tests in 
clinical medicine. Much has been learned from these tests, and their 
value and limitations have now been fairly well established.2 Such tests 
are of value for several reasons. They allow an objectiv.e appraisal of 
pulmonary function in problems of diagnosis and therapy in patients 
with cardio-pulmonary disease. They furnish a quantitative measure 
of pulmonary function so that candidates for thoracic surgery can be 
carefully evaluated both from the immediate and the long term point 
of view. Occasionally, they permit the early detection of pulmonary 
abnormalities when other methods of study have failed to find evidence 
of pulmonary disease. Finally, they allow a clearer concept of the 
mechanism of the disease process when these tests indicate that a 
specific function is altered. 
Normal Pulmonary Function 
Normal pulmonary function involves the removal of carbon dioxide 
from, and the addition of oxygen to, the pulmonary capillary blood. 
Three processes are involved in this gas exchange-ventilation, diffu-
sion and circulation, and each should be accomplished with a minimum 
expenditure of energy. 
Circulation 
Normally there is an adequate volume and distribution of pulmon-
ary capillary blood. In disease the volume of blood flowing to the 
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lungs may be reduced, as occurs after pulmonary embolism, or when 
the total cardiac output is reduced. Shunts may be present so that some 
blood bypasses the functional lung and enters the systemic circulation 
at a low oxygen tension. These are present in cases of. congenital 
arterio-venous fistulae where blood flows directly from the pulmonary 
artery to the pulmonary vein. Functional shunts exist in certain cases 
of bronchopneumonia where blood flows past alveoli that are not being 
ventilated. 
Diffusion 
Perfect diffusion implies an unobstructed exchange of carbon di-
oxide and oxygen between the alveoli and the blood in the pulmonary 
capillaries. Normally the mean partial pressure of carbon dioxide 
(Pco2) is the same in the alveoli and in the pulmonary capillary blood 
(arterial blood) . However, the mean partial pressure of oxygen (Po,) 
in the alveoli is slightly higher, by up to 10 mm. Hg., than it is in the 
arterial blood. One explanation given for this difference is that oxygen 
is only one-thirtieth as diffusible as carbon dioxide. Abnormalities in 
diffusion are seen in some cases of pulmonary fibrosis, where the fibrous 
tissue, which is deposited between the alveoli and the capillaries, presents 
a physical barrier to the transfer of oxygen. This is the syndrome of 
alveolar-capillary block.; A higher mean alveolar Po2 is therefore neces-
sary to maintain a normal Po2 of arterial blood and a normal oxygen 
saturation. If the increased alveolar Po2 is not maintained, signs and 
symptoms of anoxemia may result. 
Ventilation 
Ventilation studies are concerned with the volume of air which can 
be moved in and out of the lungs as well as with the way this air is 
distributed. Perfect distribution is present when all alveoli receive the 
same volume of inspired ai r (proportional to their previous pre-inspira-
tory volume) so that, with perfect mixing, the concentration of the gas 
in each alveolus is the same. 
Subdivisions of the Total Lung Volume 
The total volume of air that can be contained in the lungs is called 
the total lung volume; this is made up of the vital capacity, which can be 
measured directly with a spirometer, and the residual air, which must be 
estimated by indirect pteans. The point of reference from which the various 
subdivisions of the lung volume are measured is called the resting mid-
position, which is the level at the end of a normal expiration.4 The volume 
of air which can be taken into the lungs starting from this position is 
called the inspiratory capacity, while the amount that can be blown out 
from the resting mid-position is called the expiratory reserve volume. The 
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amount of air contain.ed in the lungs at the end of a normal expiration is 
called the functional residual air and is equal to the sum of the expiratory 
reserve volume and the residual air. 
The residual air is that volume of air remaining in the lungs after a 
maximal expiration. Normally it constitutes about 20ro of the total 
lung volume and is calculated by determining the volume of the func-
tional residual air by one of two commonly employed procedures. In 
Darling's open-circuit oxygen-dilution method expired air is collected 
during seven minutes of pure oxygen breathing and is analyzed for its 
nitrogen content. In the dosed-circuit helium-dilution method the pa-
tient continues to rebreathe a known concentration of helium in oxygen 
until his functional residual air is thoroughly mixed with the helium-
oxygen mixture. From the difference in helium concentration, which 
is read from a sensitive meter before and after the test, the functional 
residual air may be calculated. 
Factors Affecting the Normal Vital Capacity 
The vital capacity is the maximal amount of air that can be expired 
after a maximal inspiration. It was Jonathan Hutchinson1 who first showed 
that the vital capacity varied with body weight. More recently, Baldwin 
et aP, in a study of 90 normal individuals, devised formulae for predicting 
the normal vital capacity, and they have shown that the vital capacity 
varies directly with height and that it decreases slightly with age. How-
ever, for a given height and age, the range of the calculated vital capa-
city is quite large and may be as high as 1000 ccs.; whereas the variation 
in the same individual from day to day is small. Thus a decrease of 
300 ccs. in a patient's vital capacity probably signifies altered pulmonary 
function. The vital capacity of a large-framed individual will be greater 
than that of a small-framed individual of the same age and height. For 
a given age and body build, weight is not as important as height in de-
termining the vital capacity because an obese individual has the same 
vital capacity as his lean counterpart. 
When ventilation studies are performed, first in the sitting position 
and then in the supine position, certain changes take place. 
(1) There is a reduction of approximately 200 ccs. in the total 
vital capacity, which is probably due to an increase in the total 
pulmonary blood volume. 
(2) The expiratory reserve volume is also reduced by an even 
greater amount; when this is expressed as a percent of the total 
vital capacity it is reduced from 40ro to 25%. 
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Factors other than position have been found to affect the expiratory 
reserve volume; obesity, p regnancy and the wearing of a girdle are as-
sociated with a reduction in the sitting expiratory reserve volume6• 
It has been found that the total vital capacity does not correlate 
well with pulmonary disability. A patient with pulmonary emphysema 
will take twenty seconds to complete his vital capacity of 4500 ccs., 
whereas a normal individual will expire this same volume of air in four 
seconds. Thus the importance of speed of ventilation was recognized 
and various other tests were devised to quantitate this factor. 
One of these is the maximum breathing capacity (M.B.C.) . This 
test is performed by having the patient breathe both as quickly and as 
deeply as possible for a twelve-second period, during which time the 
total volume of air moved is measured by either a recording spirometer 
or a large Tissot spirometer. Many factors influence the performance 
of the M.B.C. The patency of the airways is the most important and 
the other factors include: the rigidity of the bony thorax, the elasticity 
of the lungs, the state of muscular co-ordination and the degree of co-
operation. The M.B.C., which is expressed in liters per minute, has 
proved to be a valuable test of ventilatory insufficiency. Other indices 
.of ventilatory insufficiency have been devised, using the M.B.C. in con-
junction with either the vital capacity or the minute volume of 
ventilation. The capacity ratio, an index of the speed of ventilation is 
M.B.C. M.B.C. - Min. Vol. 
V . 1 C .ty . The breathing reserve ratio is M B C tta apaa . . . X 100. 
Another test of the dynamic aspect of ventilation is the measure-
ment of the timed vital capacity7• If a vital capacity is energetically 
performed and a spirometer tracing recorded on a fast-moving drum, 
the resultant curve represents the maximum speed of air flow possible 
for that individual. From such a tracing (illustrated in Fig. A) , it may 
be seen that most of the air is expired during the initial phase of the 
test. Normally about SO% of the vital capacity is completed in the first 
second, and this amount is called the one-second vital capacity. As might 
be expected, the one-second vital capacity and the M.B.C. show good 
correlation in both normal and abnormal states. That the one-second 
vital capacity is the usable and important part of the total vital capacity 
can be seen when it is remembered that during exercise, the time avail-
able to complete each expiration is only about one second or less. 
Oassification of Pulmonary Insufficiency 
Let us now consider the application of pulmonary function tests 
in clinical medicine. Pulmonary insufficiency can be classified into two 
groups: 
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(1) Ventilatory insufficiency, which will be discussed below and where 
the chief symptom is dyspnea; 
(2) Alveolo-respiratory insufficiency, where the abnormality in pul-
monary function is in either distribution or diffusion and where 
the symptoms are the result of anoxemia. 
Ventilatory insufficiency can be subdivided into: 
(a) Restrictive type 
1. Thoracoplasty 
2. Pulmonary resection 
3. Kyphoscoliosis 
4. Pulmonary fibrosis 
5. Congestive heart failure 
(b) Obstructive type 
1. Asthma 
2. Emphysema 
3. Bronchostenosis 
Baldwin, makes this classification on the basis of total lung volume 
studies; the restrictive type shows a reduction in total lung volu(Ile and 
vital capacity, and the obstructive type shows an increase in the r atio 
of residual air to total lung volume. Gaensler7 differentiates restrictive 
from obstructive ventilatory insufficiency using the total vital capacity 
and the one-second vital capacity. He states that obstructive ventilatory 
insufficiency is present when the one-second vital capacity as a percent of 
the total vital capacity is reduced. These two methods of assessing ob-
structive ventilatory insufficiency, correlate well in severe cases of 
chronic pulmonary emphysema. However, in less severe cases there may 
be a normal ratio of residual air to total lung volume yet the percent 
one-second vital capacity will be reduced. 
Most cases of pulmonary insufficiency, however, show multiple 
disturbances of function, and the best example of this is pulmonary 
fibrosis. The fibrous tissue may be present in different anatomical areas 
of the pulmonary lobule and a particular function will be disturbed by 
the fibrous tissue in each location8 • Thus in the pleura or in the 
parenchyma, the fibrous tissue would lead to a reduced total vital capa-
city, while peribronchially, ventilation studies would show a reduced 
one-second vital capacity. Interstitial fibrosis would result in the syn-
drome of alveolar-capillary block, and vascular fibrosis would lead to 
abnormalities of the pulmonary circulation. 
Dyspnea, the chief symptom of ventilatory insufficiency, is defined 
as an uncomfortable consciousness of laboured breathing occurring 
when the ventilatory capacity cannot easily provide the actual ventilation. 
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Because this is a symptom involving sensation and the reaction to this 
symptom, dyspnea is very difficult to study and to quantitate objectively. 
With regard to the symptom dyspnea, we do not know its end-organ 
in the lung, its afferent pathway, or the cortical centre for its apprecia-
tion. It does not seem to be related to a reduction of vital capacity, maxi-
mum breathing capacity, oxygen saturation, partial pressure of oxygen, 
or to changes in pH. Moreover, dyspnea is not specifically a symptom 
of heart and lung disease; it also occurs in obesity and pregnancy when 
there is no evidence of cardiopulmonary disease. 
The Pattem of V eorilation 
Let us now consider the pattern of ventilation in normal individuals 
and in patients with emphysema to see whether such studies will aid 
in our understanding of dyspnea. Figure A shows a normal ventilation 
tracing taken in the sitting position. The total vital capacity of 5100 ccs. 
is normal for height and age. The expiratory reserve volume comprises 
40% of the vital capacity and the inspiratory capacity 601o· The one-
second vital capacity is 4200 ccs. or 821o of the total. It will be seen 
that the speed of air flow is initially very rapid and does not decrease 
until approximately 4200 ccs. or 821o of the total vital capacity has been 
expired. The resting mid-position has been reached in less than one 
second after the commencement of the vital capacity determination. 
This individual, then, is normally breathing in an area where he can 
move air very rapidly. In other words, he is breathing on the steep part 
of his vital capacity curve. 
Figure B shows the pattern of ventilation in a patient with chronic 
pulmonary emphysema. The total vital capacity of 3680 ccs. is slightly 
reduced, the expiratory reserve volume comprises 45% and the inspira-
tory capacity 551o of the vital capacity. The important abnormality in 
this patient, however, is the reduced one-second vital capacity which is 
only 900 ccs. or 241o of the total. This patient is unable to attain the 
high rates of air flow that the normal individual can. The resting mid-
position is not reached during the vital capacity determination until 
about two seconds have elapsed. This patient is then breathing in an 
area where he cannnot move air rapidly. In other words he is breathing 
on the slope of his vital capacity curve. 
The shape of the vital capacity curve depends upon the resistance 
offered by the lungs and thorax to the flow of air. The respiratory 
passages, especially the terminal bronchioles, contribute, to a large 
degree, to this total pulmonary resistance. Resistance is also offered 
by the lungs and thorax to a change in their shape incidental to the act 
of breathing, but this is less important during inspiration than during 
expiration. 
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The Pattern of Ventilation in a Normal Subject and in a Patient with 
Emphysema: 
· A. Normal Ventilation Tracing. 
Tracing was recorded from right to left. The two marks on the vital 
capacity curve represent the one-second and two-second vital capacities which 
constitute 82% and 95 % of the total. The maximum breathing capacity (M.B.C.) 
is shown at the extreme left. The lower pen, which is geared to the upper pen 
is a 25 : 1 ratio, measures the total volume of air moved during the test. This 
individual is breathing on the steep part of his vital capacity curve. 
B. Tracing from a Case of Chronic Pulmonary Emphysema. 
The one-second and two-second vital capacities are 24% and 44% of the 
total. This patient is breathing on the slope of his vital capacity curve. 
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The work involved in moving a given amount of air will depend 
upon the resistance offered to the flow of air and upon the time taken 
to move this air. The work of breathing will thus be greater in a patient 
with emphysema, who breathes on the slope of his vital capacity curve, 
than in a normal individual who breathes on the steep part of his vital 
capacity curve. Although quantitative data is meagre for the pulmonary 
resistance and the work of breathing9, many investigators believe that 
dyspnea is related in some way to the work of breathing. 
The Use of Ventilation Studies 
The majority of pulmonary function tests require elaborate and 
expensive equipment and a trained technical team. Ventilatory func-
tion, on the other hand, can be assessed relatively easily and quickly with 
a minimum of equipment. A recording spirometer, which can be oper-
ated at fast speed is most suitable for these studies because it allows 
estimation of the tidal and minute volume, total and timed vital capacity, 
and the maximum breathing capacity. A rough approximation of the 
presence of obstructive ventilatory insufficiency can also be made if the 
volume of the vital capacity is divided by the elapsed time. A normal 
male will complete his vital capacity of 4000 ccs. in 4 seconds (ratio 
1000:1) while an asthmatic will require 10 seconds to expire this same 
volume (ratio 400:1). Gaensler7 has devised a simple and inexpensive 
vitalometer with an electronic timing device with which one can quickly 
determine the vital capacity and the one-second vital capacity. 
It is interesting to note that the subcommittee on pulmonary func-
tion tests of the American Trudeau Society considered the following to 
be the minimum requirements in evaluating a patient's pulmonary func-
tion10, "careful analysis of history; physical examination; a fluoroscopic 
examination which attempts to evaluate the magnitude; speed and dis-
tribution of pulmonary ventilation; inspiratory and expiratory chest 
X-rays; and a determination of the maximum breathing capacity." They 
went on to say that these minimum requirements could be performed in 
any hospital or sanitorium dealing with diseases of the chest. 
Finally, there are definite limitations to pulmonary function tests. 
There is no one single test of pulmonary function. These are physio-
logical tests and do not make a pathological diagnosis, and they do not 
localize disease in the lungs. 
Summary 
Pulmonary function tests allow an objective assessment of the state 
of pulmonary function in patients with diseases of the heart and lungs. 
Of the many tests available, those assessing ventilatory function are the 
simplest to perform. 
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When a vital capacity determination is made using a recording 
spirometer with a fast paper speed, the tracing shows not only the speed 
of ventilation and the total volume of air moved, but also the relation 
of the resting mid-position of respiration to the vital capacity curve. 
A classification of ventilatory insufficiency based on the measurements 
of the total and one-second vital capacities is presented. It must be borne 
in mind that a pulmonary function study will not tell where the lesion is, 
what the lesion is, or even that a lesion exists, unless it interferes with the 
normal function of the lungs. 
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• The American Congress of Physical Medicine and Rehabilitation 
is sponsoring the 
FIRSf ANNUAL ESSAY AWARD 
To stimulate interest in the field of physical medicine and rehabilitation, the 
American Congress of Physical Medicine and Rehabilitation will award 
annually a prize for an essay on any subject relating to physical medicine and 
rehabilitation. The contest, while open to anyone, is primarily directed to medi-
cal students, internes, residents, graduate students in the pre-clinical sciences 
and graduate students in physical medicine and rehabilitation. 
Any subject of interest or pertaining to the field of physical medicine and re-
habilitation may be submitted. 
Manuscripts must be in the office of the American Congress of Physical Medi-
cine and Rehabilitation, 30 N. Michigan Ave., Chicago 2, not later than 
June 1, 1953. 
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WHO Notes: 
Influenza Today 
A. M. M. Payne, MD.: M.R.C.P.* 
The World Health Organization · plays an important role in world 
medicine today and often people do not realize the importance of the work 
carried out by this important specialized agency of the U.N. With the 
publication of this article, the Editon hope that we can bring to our rellllers 
timely and interesting articles of the work of W.H.O. 
Influenz~ is news. Each time an in-
fluenza epidemic appears on any large 
scale - and this happens every two 
or three years - frequent reports in 
the Press reflect public interest and 
anxiety. Memory of the 1918-19 pan-
demic dies hard, and it is right that 
it should live since we do not know 
what combination of circumstances 
brought it about, nor whether it will 
ever occur again. Nevertheless, no sub-
sequent epidemic has been on such a 
scale or of such severity as to justify 
comparison with that disaster. And 
yet the comparison has been made in 
some reports even in this year's mild 
epidemic, whereas other reports have 
contained too optimistic views on the 
prospects for controlling the disease. 
Such inaccuracies are perhaps inevit-
able in this age of speed, for there is 
not time to double-check the accuracy 
of a report on an incident 5,000 miles 
away when the public demands that 
the news should be on the breakfast 
table next morning; and the objective 
assessment of new control measures 
is a slow process requiring years of 
patient observation in which there is 
no place for impatient enthusiasm. 
The purpose of this article is to give 
an account of this year's epidemic up 
to the end of January, based on con-
firmed reports, illustrating the way in 
which the World Health Organization 
is helping to tackle the problem of in-
fluenza, together with some specula-
tions regarding the future- prospects 
for controlling the disease. 
But first it is necessary to consider 
some technical facts. Three main types 
of the virus of influenza have so far 
been discovered; the two most import-
ant of them - A and B - comprise 
several sub-groups which in the case 
of Virus A may differ so much as to 
afford little or no protection following 
infection or vaccination from sub-
sequent infection by a virus of a dif-
ferent sub-group. During an epidemic 
the virus breeas true within certain 
limits, that is to say an outbreak due 
to one strain of Virus A is not related 
to one due to a different strain, even 
if it occurs nearby and at about the 
same time. From time to time new 
strains appear which may be quite dif-
ferent from previously known strains 
both as far as protection by vaccination 
•Dr. A_ M. M. Payne is associated with the Division of Communicable Disease Services. World 
Health Organization. 
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is concerned and also in their ability 
to cause epidemics and to kill. The 
consequence of these facts are that 
epidemiological reports can only be 
correctly interpreted in terms of labor-
atory studies of the viruses responsible; 
that successful vaccination against in-
fluenza depends on knowledge of the 
virus causing the epidemic; and that 
continuous vigilance is necessary to 
detect new and potentially dangerous 
strains at the earliest possible moment. 
Epidemiology 
It was with these facts in mind that 
in 1947 the Interim Commission of 
the W odd Health Organization ini-
tiated a world-wide network of influ-
enza laboratories by setting up the 
World Influenza Centre in London for 
the study and comparison of strains of 
virus isolated in different parts of the 
world. This was a logical develop-
ment of a similar network previously 
set up by the Armed Services Commis-
sion on Influenza in the United States 
of America. A second reference labor-
atory in New York, known as the 
Strain Study Centre for the Americas, 
is co-ordinating the work in the Amer-
icas. The world network now includes 
55 laboratories in 44 different coun-
tries. Many more laboratories are co-
operating informally. 
The work of these laboratories con-
tinues summer and winter, for new 
strains may appear during the sum-
mer and the strains causing epidemics 
during the winter in the southern 
hemisphere may spread to the north-
ern hemisphere to cause outbreaks 
there a few months later. This ap-
parently occurred during the 1950-51 
outbreak when a strain of A-prime 
virus isolated in South Africa and Aus-
tralia during June was found to be 
identical with one causing a severe 
outbreak in Liverpool in the following 
January. This became known as the 
Liverpool subtype; another simultane-
ously present in Western Europe was 
called the Scandinavian subtype. 
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In 1952, laboratories in the WHO 
network again isolated an A-prime 
strain (Liverpool subtype) in South 
Africa in May, and the similarity of 
the circumstances to those of 1950 
caused the World Influenza Centre to 
issue in June a cautious warning that 
there might be an outbreak due to this 
strain this winter, but that it would 
quite probably not be clinically severe 
since partial immunity may have per-
i ted from the 1950-51 epidemic. 
In the latter half of December in-
fluenza was reported in the United 
States of America in the State of Mis-
souri, the virus being similar to Scan-
dinavian 1951 A-prime virus. Numer-
ous isolations of virus throughout the 
country confirmed that an A-prime 
virus was responsible for the outbreak. 
although, as is frequently the case, a 
few sporadic cases of Influenza B were 
detected. The epidemic continued to 
increase during the first three weeks 
of January, with a small increase in 
the number of deaths attributed to in-
fluenza and pneumonia. Towards the 
end of January there were indications 
that in some states at least the epi-
demic had reached its peak. 
In the United Kingdom a mild form 
of influenza spread across southern 
England and Wales in the first half 
of January, and began to appear as 
localized outbreaks in the midlands 
and north in the third and fourth 
weeks. The epidemic had not reached 
Scotland by the end of the month. 
Several strains of virus have been 
identified as A-prime resembling the 
1951 Scandinavian type and generally 
similar to the strains isolated in 
the U.S.A. but slightly different 
from the 1953 strains from Paris and 
Switzerland. 
Outbreaks were also reported begin-
ning in December in various parts of 
the Pacific region, including the Phil-
ippines, Hawaii and Japan, where the 
vi rus was identified as A-prime. 
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The true interpretation of the epi-
demiological data must await the re-
sults of further careful studies and 
comparisons of the viruses isolated in 
various parts of the world. However, 
it is clear that the viruses responsible 
for this epidemic are of the A-prime 
type and closely related to strains iso-
lated in 1950-51. 
Vaccination 
This is fortunate because several 
large-scale trials of influenza vaccines 
had been planned this winter by na-
tional organizations in the U.S.A., 
Canada, the United Kingdom and the 
Netherlands. These would have been 
of much less value if there had been 
no epidemic or if the responsible virus 
had shown unusual characteristics. As 
it is, important information may be 
hoped for from these trials both as 
to the effectiveness of the vaccines 
used and how best to use them. 
Unfortunately vaccination against in-
fluenza produces neither as lasting nor 
as complete an immunity as does, for 
example, vaccination against smallpox. 
In controlled trials in the past the un-
protected individuals have been at-
tacked about four times as often as 
the inoculated, but a number of the 
latter still become ill with the disease, 
and the degree of protection has prob-
ably waned considerably after a year. 
It must be stressed that the vaccines 
at present under test lend no hope of 
being able to eliminate the disease; the 
best that can be hoped for is to limit 
the effects of an epidemic by reducing 
the number of people who fall sick 
and hence diminishing the economic 
effects of the epidemic which are some-
times serious. All claims of the suc-
cessful control of influenza must be 
interpreted in this strictly limited sense. 
If by control measures the effect of 
an epidemic of influenza could be re-
duced throughout a country to one-
tenth of what it would otherwise be, 
that would indeed be a success. It can-
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not be achieved at present.· There are 
several difficult problems which must 
be solved first. 
Primarily there is the unpredict-
ability of the influenza virus, which 
shows no stability in nature. This is 
being tackled, as already explained by 
an "intelligence service", in the shape 
of the WHO network of laboratories 
which is constantly studying changes 
in the virus as they appear, and this, 
it is hoped, may eventually lead to the 
ability to forecast epidemics with rea-
sonable reliability. 
Further, a great deal remains to be 
learnt about the best methods of pro· 
ducing, testing and using vaccines. 
There is, for example, a relatively new 
type of vaccine under test which ap-
pears to have advantages in the degree 
and duration of immunity produced, 
together with economy in the amount 
of virus needed. There is no doubt 
that if this is confirmed and the safety 
of the vaccine proven it will rt:present 
a major advance; however, at the pres-
ent time it must be con:~· fered 
experimental. 
The use of influenza vaccines pre-
sents a number of problems. It is 
dearly impracticable to vaccinate the 
whole population each year owing to 
the great expense and difficulties of 
such a scheme. The questions are whom 
to inoculate and when. The answers 
will depend a great deal on local con-
ditions and economy. It is hoped that 
some guidance on this will be forth-
coming as a result of the trials at 
present in progress. 
An important function of all health 
authorities is the protection of the pub-
lic from dangerous, inferior or in-
active products. To effect this it is 
necessary to lay down tests and stand-
ards to which products must conform. 
Although this has been done in some 
countries, there are, as yet, no uni-
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versally agreed standards for influenza 
vaccine which are needed before it can 
take its place as a fully recognized 
preventive agent. 
influenza altogether, and indeed fur-
ther research and cateful observations 
are needed before the best methods 
of preparation and use of vaccines 
can be decided. 
To sum up it may be stated that 
there is good reason to believe that 
influenza vaccines will play a princi-
pal role in lessening the effects of in-
fluenza epidemics in the future. How-
ever, they give no hope of eliminating 
Nevertl\eless, a great deal of re-
search work is in progress and it may 
be hoped that solutions to many prob-
lems will be found in the not far dis-
tant future. 
NJM. 80GIIIl . . . 
• Post-Graduate Symposium of the Basic Sciences 
Related to Anesthesiology 
June 8-12, 19S3 
Will be held at the 
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDIONE 
Pittsburgh, Pa. 
Registration fee $2500 
Th"s course will be limited to 50 participants. For full particulars write: 
~ •- Chairman of the Committee on Graduate Medical Education 
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE 
3941 O'Hara Street, Pittsburgh 13, Pennsylvania 
• Schering Award Competition, 1953 
Three $500 prizes will be awarded for the papers judged most distinctive 
by a panel of leading medical authorities on the subjects covered. 
Titles of the general topics are: 
1. Antihistaminic Treatment of Upper Respiratory Allergies and Infections. 
2. Hormone Therapy of the Degenerative Diseases. 
3. New Concepts in the Treatment of Peptic Ulcer. 
This year numerous $100 Deans' Awards will be presented and in each 
school where several students compete, the Dean is invited to select the most 
meritorious paper. 
The deadline for entry forms specifying the title chosen by the student is 
July 1. The actual -manuscript must be postmarked by October 1 . 
Information and instructions for the competition are available from : 
THE SCHERING CORPORATION 
2 Broad Street, Bloomfield, New Jersey 
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Books • Review: tn 
THE SYMPTOMS AND TREAT-
MENf OF ACUTE POISONING 
G. H. Lucas, Professor of Pharmacology, 
University of Toronto. P. 380. Clarke, 
Irwin & Co., Toronto, 1952. 
This is a practical book in toxi 
cology designed both for students and 
medical practitioners. It reflects the 
wealth of experience gained by Doctor 
Lucas over a period of many years. 
After general considerations, the 
useful drugs and apparatus which the 
physician will require to treat the pa-
tient, both before and after admission 
to hospital, are discussed. They are 
treated separately in regard to indi-
cations, dose and mode of administra-
tion. Very practical information is 
g iven in the use of emetics and gas-
tric lavage. The directions for the use 
of the latter are especially good. One 
chapter is devoted to the problem of 
poisoning in children. He stresses the 
falsity of prescribing burned toast as 
a substitute for activated charcoal. The 
importance and methods of collection 
of samples for the analyst, such as 
stomach wastings, etc., are stressed. 
The greater part of the book is taken 
up with " Cases of Poisoning". This 
includes the signs, symptoms and treat-
ment of individual poisons. The ma-
terial is arranged in an orderly and 
practical manner . All the newer 
poisons, such as "Toxaphane", "Par-
athion", etc., and antidotes such as 
B.A.L. are included. 
The book is an excellent contribu-
tion to the diagnosis and treatment 
of poisons. Medical students and prac-
ti tioners will find it invaluable. 
-R. A. WAUD, M.D. 
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PEDIATRICS IN 
GENERAL PRACTICE 
Jonus G. Hughes, B.A., M.D., Professor 
oj Pediatrics, University of Tennessee, 
College of Medicine, Memphis. 1st 
edition, P. 7 38, illust. McGraw-Hilt 
Book Compa11y of Canada limited, 
1953. 
This up-to-date book on pediatrics 
is a boon to the general practitioner 
and to the medical student. In 738 
pages the common problems of pedi-
atrics in general practice are presented 
in a real and creative manner. Dr. 
Hughes gives us a dear conception of 
the disease processes and presents a 
rational and practical routine of man-
agement. The remarkable clarity of 
thought makes reading very enjoyable 
and easy, but there is no over-
simpl ification . 
This book is different, in that, it 
is not too extensive to be laborious, 
however, ooe might criticize it, in that, 
there is a lack of detail on the more 
obscure problems in pediatric medi-
cine, but this criticism is essentially 
unfounded because great detail would 
take away from the dearness and di-
rectness which is so characteristic of 
the text. There is an extensive bib-
liography at the end of each chapter 
for those who would voice the above 
criticism. 
The author, on the other band, is 
academic enough to present his read-
ers with basic sound principles and 
be does this in his first four chapters 
on the new born infant, infant nutri-
tion, nutritional disturbances and prob-
lems of fluid and electrolyte balance. 
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With such a background the reader 
can better assimilate the content of 
the chapters in which pediatric prob-
lems are organized into systems. Pre· 
ventive medicine with immunization 
and control of infectious diseases so 
important in pediatrics is stressed and 
some emphasis is placed on subjects 
such as allergy and the psychological 
aspect of childhood. 
The excellent pbotog.raphs, x-ray 
photographs and diagrams are essen-
t ial to a vivid presentation. The 
spacing and headings on every page 
give the book still another advantage. 
- T. RICHARDS, '53. 
LOGAN TURNER'S DISEASES OF 
THE NOSE, THROAT AND EAR 
Ed. William Guthrie. MacMillan Co., 
Canada, P. 478, illust. 1952. 
This is a complete revision of a 
textbook which has enjoyed great pop-
ularity in the past. The fourth edition, 
edited by Dr. Logan Turner of Edin-
burgh, was published in 1936 and has 
been out of print for some years. 
Dr. Douglas Guthrie, the sole survivor 
of those contributing to earlier edi-
tions, is the editor of this fifth edition 
which like former ones, is planned 
primari ly for senior medical students 
and practitioners. It contains funda-
mental knowledge upon which the 
specialist may build. ·· 
In the manner of previous editions, 
the book is divided into seven sections: 
Diseases of the Nose, Affections of the 
Paranasal Sinuses, The Pharnyx and 
Nasopharnyx, The Larnyx, Peroral 
Endoscopy, Diseases of the Ear and a 
brief section on The Sulphonamides 
and Antibiotics. This last section re-
places one on formulae for use in the 
diseases discussed. 
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The content of the book, although 
similar in style to that of previous 
editions, has many additions and bas 
been in places drasticaiiy revised. 
Beside the sections on therapeutics, the 
discussion of disorders of voice, teach-
ing of the deaf and artificial hearing 
aids are among those which have been 
greatly changed. Modern methods of 
endoscopy are discussed. There are 
numerous small changes throughout 
the text such as the replacement of a 
discussion of nasal neuroses by one on 
allergy and similar conditions in the 
nose. 
Descriptions of clinical conditions 
are concise, but contain adequate in-
formation for the person encountering 
them in general practice. Short notes 
concerning the embryological and post-
natal development of the paranasal 
sinuses, tonsils, middle ear and ex-
ternal ear are helpful in understanding 
disease processes of these organs. The 
es entia! facts about treatment are 
present, but the many fine details 
which are learned by practical exper-
ience are omitted. To further help stu-
dent , many forms of treatment are 
visualized in illustrations. The entire 
rna s of information is handled in such 
a way that there is little overlapping. 
The subject matter is similar to that 
in other such textbooks, although dis-
ease of the skin over the nose and 
ear are not discussed nearly as fully 
as in most ear, nose and throat text-
books. There is no bibliography or 
references. 
All in all, this is a moderate sized 
book which will be welcomed by stu-
dents and practitioners as an easily 
read, authoritative textbook upon the 
nose, throat and ear. 
- LILLIAN M. BEATTIE, '54. 
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Alumni News: 
• Dr. R. G. Knipe, lecturer in the 
Department of Clinical Preventive 
Medicine and Director of the Elgin-
St. Thomas Health Unit has recently 
resigned the above posts and has 
accepted the Directorship of the 
County Health Unit, Batavia, N.Y. 
J, M.,.,..u,, . . . 
• William T. Banting '92, died at 
his home in Lucan, Ontario, on March 
16 at the age of 85. After graduation 
Dr. Banting practised in Lexington, 
Michigan, for 10 years before he estab-
lished his practice in Lucan. 
• Manley G . Peevers '21, died March 
17 at the age of 57 following a brief 
illness. Well known as a sportsman 
and a surgeon, Dr. Peevers was on the 
medical staff at St. Joseph's Hospital, 
London, and held the post of Alumni 
Representative on the University's 
Board of Governors. 
After graduating he did three years' 
post-graduate work at Johns Hopkin 
Hospital, Baltimore, and in New York 
City. In 1924 be returned to London 
and worked with the late Dr. W. J. 
Stevenson. During the following years, 
Dr. Peevers gained local, national and 
international repute for his surgical 
skill. 
• Howard C. Moloy '27, died March 
13 at the age of 60. Dr. Moloy was 
assistant attending obstetrician and 
gynecologist at the Columbia-Presby-
terian Medical Centre and a member 
of the teaching staff at the College of 
Physicians and Surgeons, Columbia 
University. 
He gained international recognition 
for his research and writings in his 
chosen field . Most of his research was 
carried out in the field of Roentgen 
pelvimetry and it was through this 
work that the Caldwell-Moloy classi-
fication of female pelves was de-
veloped. Much of Dr. Moloy's work 
had to do with perfecting radiological 
tochniques to foresee possible compli-
cations in childbirth. 
• Interne placements were announced on March 16, much to the interest of 
all medical undergraduates, and particularly to the concern of those preparing 
for the "Councils". The Meds of 'H are by no means leaving the Western 
fold, but are now entering upon greater vistas of achievement and from those 
who are following in their footsteps, we wish them the best of luck and 
au revoir- 'H! 
NAME HOSPITAL 
BAGSHAW, John .. .............. ..... ....................... Hamilton General, Hamilton, Ont. 
BOLES, Murray ..... ............... ... ............... .. ... .... ........................... Grace, Detroit, Mich. 
BOYES, James ........................ .. .................. ..... ..... ...... .............. Mercy, Baltimore, Md. 
BOYES, Truman ................................................. ....... St. Vincents, New York, N.Y. 
BRUNER, George .................................... .............. .......... St. Joseph's, London, Ont. 
CARROLL, Edwin ..... ..... .... .. ............. ............ ...... ....... ............ Victoria, London, Ont. 
CLANCY, Patrick .. ......................................... .... ............... St. Joseph's, London, Ont. 
CLIFf, Allan .... ................................. ...... ...... ...... .......... .. ... St. Joseph's, Lon.don, Ont. 
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CRANG, Donald ...................................................... Toronto General, Toronto, Ont. 
CROWLEY, Patrick .............................................. Mt. Carmel Mercy, Detroit, Mich. 
DENNIS, Marion .................................................................... Victoria, London, Ont. 
DOUGALL, Ross ........................ .. .......................................... Victoria, London, Ont. 
FODERICK, Peter ................................................................ Ancker, St. Paul, Minn. 
GARWOOD, Gordon ....................................................... St. Joseph's, London, Ont. 
GRANT, James ............................................... Vancouver General, Vancouver, B.C. 
HANNAH, Walter ................................................ Toronto Western, Toronto, Ont. 
HOLMES, Robert... ................... George Washington University, Washington, D.C. 
HUNTER, Andrew ................................................ Toronto Western, Toronto, Ont. 
JAMES, Kenneth ...................................................................... Victoria, London, Ont. 
KENT, R. W .. .................................................... Brantford General, Brantford, Ont. 
KENT, Wallace ............ ................ .... ..... ............... .. ...... .... St. Joseph's, London, Ont. 
KOVAL, Andrew .................................................................... Victoria, London, Ont. 
LANSING, Allan ... ............................................ ..................... Victoria, London, Ont. 
LaROCQUE, Raymond ............................ .. ...................... Hotel-Dieu, Windsor, Ont. 
LOCKWOOD, Charles ............................... ....................... St. Joseph's, Toronto, Ont. 
LOVEGROVE, Thomas .......................................................... Victoria, London, Ont. 
McCONNELL, John ....................................... Vancouver General, Vancouver, B.C. 
McJANNETT, William ..... .......... ............. University of Alberta, Edmonton, Alta. 
McLEISH, John ................................................................. St. Joseph's, London, Ont. 
MARCHUK, Peter.. ............................ ......... ............ Royal Victoria, Montreal, Que. 
MARRIOTT, Douglas ................................... ..... Hamilton General, Hamilton, Ont. 
NICHOL, James .......... ............................................................................ Not Interning 
NICHOLSON, Robert.. .......................................................... Victoria, London, Ont. 
OLSON, Clifford .............................................. Vancouver General, Vancouver, B.C. 
ONERHEIM, William ................................................ Regina General, Regina, Sask. 
PATTERSON, Thomas ..................................... ...... ............... Victoria, London, Ont. 
POWER, Lawrence ........ ................. ............ ... .................... St. Joseph's, London, Ont. 
PROUD, John .................................................... Hamilton General, Hamilton, Ont. 
RICHARDS, Burke .............................................. Montreal General, Montreal, Que. 
RICHARDS, Jo-Anne ............................................................. Victoria, London, Ont. 
RICHARDS, Terrence ........................................................... Victoria, London, Ont. 
RICHARDSON, Stanley ........ George Washington University, Washington, D.C. 
ROBINSON, Martio ................................................ Toronto General, Toronto, Ont. 
RUNDLE, Alan ........................................................................ Victoria, London, Ont. 
SANBORN, Shannon .......... ..... ............................ Toronto Western, Toronto, Ont. 
SCHILLER, Honore ......................................................... Hotel-Dieu, Windsor, Ont. 
SHAW, Robert .................................................................. St. Joseph's, Toronto, Ont. 
SMITH, Delbert.. ................................................ Hamilton General, Hamilton, Ont. 
SMOUT, Marvin ..................................................................... Victoria, London, Ont. 
STAPLEFORD, Edmund ....... George Washington University, Washington, D.C. 
SWARTZ, Gerald ................................................ Montreal General, Montreal, Que. 
TAYLOR, James ...................................... .................... Regina General, Regina, Sask. 
TEW, William ........................ .... ...... ... ................... Toronto General, Toronto, Ont. 
THOMPSON, Robert.. .... .. .................................................... Victoria, London, Ont. 
TWELVES, John .................. .. ............................ Hamilton General, Hamilton, Ont. 
WALKER, John ..................................................................... Victoria, London, Ont. 
WALL, Charles ............................................................... St. Joseph's, London, Ont. 
WALSH, Milton .................... ..... ....................................... St. Joseph's, London, Ont. 
WHITE, James .................................................... Hamilton General, Hamilton, Ont. 
ZAHARUK, Walter.. ................ .. .................................... St. Joseph's, London, Ont. 
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BEN 
BRYANT 
''YoUr Druggist" 
377 Ricbmoad St. 
Our Motto: 
"PRESCRIPTIONS FIRST" 
In addition to a thoroughly modem 
ecieotific approach to the patient's prob-
lems. Homewood 11tl'e88ell the advantage 
of a homelike environment for nervoue 
and mild mental dieorden, peychooeoroeill 
and a limited number of habit caeee and 
caeee of eenility all under the individual 
care of Psychiatric Specialillte and Pby-
eiciane and a competent Psychiatric staJI'. 
All modem therapy ill available. includ-
ing P sycbotherapy.lnsulin. Electroehock 
and Electronarcosill combined with excel-
lent Occupational and Recreational 
faciliti.ee. Homewood ill eituated in over 
90 aCI'ell of beautiful woode and 8owerinf: 
lawna. and providee accommodation for 
over 200 patientll. Pbyeicianll and tboee 
intereeted are invited to villit Homewood 
or to write for an illustrated Fold« to: 
For Insurance 
of All Types 
Call 
Associate 
ROY WILLIAMS 
10 WRIGHT BLDG. 
or PHONE .o{-8?.(7 
• life 
• liability 
• floaters 
• automobile 
• fire 
A. L MaciiNNON, M.l., Meclcal S!!pt. 
THE HOMEWOOD SANITARIUM OF 
GUELPH, ONTARIO, LIMITED 
